More information for better patient care hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477, to amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the regulation of food, drugs, devices, and biological products, February 22, 1996.

Similar Items

• Discussion draft of the Food and Drug Administration Globalization Act legislation device and cosmetic safety provisions : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 14, 2008.
  Imprint: (2008)
• FDA regulation of medical devices, including the status of breast implants joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995.
  Imprint: (1996)
• The GMP letter
  Imprint: (1980)
• Revitalizing new product development from clinical trials through FDA review hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996.
  Imprint: (1996)
• The impact of medical device and drug regulation on innovation, jobs, and patients a local perspective : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, September 26, 2011.
  Imprint: (2012)